CTLA4 and neoplasm: Tumor cells express immune checkpoints such as the ligand of programmed death protein 1 (PD-L1), cytotoxic T lymphocyte-associated antigen-4, (CTLA-4), and lymphocyte activation gene 3 (LAG3), which inhibit the immune response.